New 52 Week High Today

New 52 Week Low Today

Caribou Biosciences Inc CRBU:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/23/21 EDT
16.60quote price arrow up+0.28 (+1.72%)
Volume
98,389
Close
16.32quote price arrow up+0.32 (+2.00%)
Volume
6,717,701
52 week range
16.32 - 19.68

...

Loading . . .
  • Open17.65
  • Day High19.68
  • Day Low16.32
  • Prev Close16.32
  • 52 Week High19.68
  • 52 Week High Date07/23/21
  • 52 Week Low16.32
  • 52 Week Low Date07/23/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open17.65
  • Day High19.68
  • Day Low16.32
  • Prev Close16.32
  • 52 Week High19.68
  • 52 Week High Date07/23/21
  • 52 Week Low16.32
  • 52 Week Low Date07/23/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Caribou Biosciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Caribou Biosciences, Inc. is a United States-based clinical-stage biotechnology company. The Company uses clustered regularly interspaced short palindromic repeats (CRISPR) genome editing to discover and develop immune cell-based therapeutics for cancer. It is focused on developing a pipeline of genome-edited off-the-shelf CAR-T cell and natural killer (NK) cell therapies for a range of tumor types. It also offers licenses to its CRISPR-Cas9 foundational IP in multiple fields...
Rachel Haurwitz Ph.D.
President
Jason O'Byrne
Chief Financial Officer
Address
2929 7th St Ste 105
Berkeley, CA
94710-2753
United States